https://www.macrotrends.net/stocks/charts/AMPH/amphastar-pharmaceuticals/current-ratio
Amphastar Pharmaceuticals Current Ratio 2012-2026 | AMPH | MacroTrends
Amphastar Pharmaceuticals current ratio from 2012 to 2026. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay...
amphastar pharmaceuticalscurrent ratiomacrotrends
https://markets.businessinsider.com/bonds/amphastar_pharmaceuticals_incdl-exchang_notes_202329-bond-2029-us03209rab96
AMPHASTAR PHARMACEUTICALS INC.DL-EXCHANG. NOTES 2023(29) Bond | Markets Insider
AMPHASTAR PHARMACEUTICALS INC.DL-EXCHANG. NOTES 2023(29) (US03209RAB96) - All master data, key figures and real-time diagram.
amphastar pharmaceuticalsmarkets insiderincdlnotes
https://markets.traderfox.com/aktien/11259178-amphastar-pharmaceuticals
Amphastar Pharmaceuticals Inc. Aktie
Amphastar Pharmaceuticals Inc. Aktie - aktueller Kurs, Echtzeit-Charts, Fundamentaldaten | US03209R1032 | A11664
amphastar pharmaceuticalsincaktie
https://340breport.com/amphastar-pharmaceuticals-42nd-drugmaker-to-place-340b-contract-pharmacy-restrictions-5th-to-use-truzo/
Amphastar Pharmaceuticals 42nd Drugmaker to Place 340B Contract Pharmacy Restrictions, 5th to Use...
May 7, 2026 - A California-based drugmaker this week announced new contract pharmacy restrictions for covered entities looking to purchase a low blood sugar treatment A...
amphastar pharmaceuticalsplacecontractpharmacyrestrictions
https://www.facilitamedicamentos.com.br/marca/amphastar-pharmaceuticals-inc/
AMPHASTAR PHARMACEUTICALS, INC Archives - Facilita Medicamentos
amphastar pharmaceuticalsincarchivesmedicamentos
https://www.cafc.uscourts.gov/5-14-2008-2007-1280-aventis-pharma-v-amphastar-pharmaceuticals-07-1280/
2007-1280: AVENTIS PHARMA V. AMPHASTAR PHARMACEUTICALS, Precedential - U.S. Court of Appeals for...
Aug 3, 2015 - Opinions/Orders posted: AVENTIS PHARMA V. AMPHASTAR PHARMACEUTICALS(pdf) Appeal Number: 2007-1280 Origin: DCT Precedential To see more opinions and orders,...
court of appealsamphastar pharmaceuticalsaventis
https://www.panabee.com/news/amphastar-pharmaceuticals-earnings-q2-2025
Amphastar Pharmaceuticals Earnings Q2 2025 | Amphastar Pharmaceuticals News & Analysis
Amphastar Pharmaceuticals reported a 4% overall revenue decline in Q2 2025 despite BAQSIMI sales soaring 51% to $46.7 million, as strong growth in its new...
amphastar pharmaceuticalsnews analysisearnings
https://www.pharmiweb.com/search/?query=%23Amphastar%20Pharmaceuticals%23&type=4
#Amphastar Pharmaceuticals# - Search Results - PharmiWeb.com
Search our press releases, events, articles and pwtoday stories
amphastar pharmaceuticalssearch results
https://live.deutsche-boerse.com/bond/us03209rab96-amphastar-pharmaceuticals-inc-2-23-29
Amphastar Pharmaceuticals Inc. 2% 23/29 Bond | A3L3SW | US03209RAB96 | Price
Amphastar Pharmaceuticals Inc. 2% 23/29 price in real-time (A3L3SW / US03209RAB96) charts and analyses, news, key data, turnovers, company data.
amphastar pharmaceuticalsincbondprice
https://sharepredictions.com/options/amph/
AMPH Options - Amphastar Pharmaceuticals, Inc. Call & Put Options Chain | Share Predictions
AMPH options chain with Greeks, IV, and volume. View Amphastar Pharmaceuticals, Inc. call and put options. Free real-time data.
amphastar pharmaceuticalsoptionsinccallput
https://www.nasdaq.com/market-activity/stocks/amph/institutional-holdings
Amphastar Pharmaceuticals, Inc. Common Stock (AMPH) Institutional Holdings | Nasdaq
Find the latest institutional holdings data for Amphastar Pharmaceuticals, Inc. Common Stock (AMPH) including shareholders, ownership summaries, and holding...
amphastar pharmaceuticalscommon stockinstitutional holdingsincnasdaq
https://lifestyle.all80sz1063.com/story/86622/amphastar-pharmaceuticals-reports-financial-results-for-the-three-months-and-full-year-ended-december-31-2025/
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended...
amphastar pharmaceuticalsfinancial resultsfor thethree monthsfull year